Next Article in Journal
Synthesis and Evaluation of [67Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4
Previous Article in Journal
Scientia Pharmaceutica, Autorenhinweise 2011
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 79
Issue 2
10.3797/scipharm.1012-17
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]- piperidine-2,6-diones

by
Anna BIELENICA
1,*,
Jerzy KOSSAKOWSKI
1,
Marta STRUGA
1,
Izabela DYBAŁA
2,
Roberta LODDO
3,
Cristina IBBA
3 and
Paolo LA COLLA
3
1
Department of Medical Chemistry, First Faculty of Medicine, The Medical University of Warsaw, 3 Oczki Street, 02-007 Warsaw, Poland
2
Department of Crystallography, Faculty of Chemistry, Maria Curie-Sklodowska University, 3 Maria CurieSklodowska Square, 20-031 Lublin, Poland
3
Department of Biomedical Science and Technology, University of Cagliari, 09042 Monserrato (CA), Italy
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2011, 79(2), 225-238; https://doi.org/10.3797/scipharm.1012-17
Submission received: 16 December 2010 / Accepted: 10 February 2011 / Published: 12 February 2011
Versions Notes

Abstract

A set of 13 alkyl derivatives of 3-phenylpiperidine-2,6-dione were synthesized. Newly obtained compounds were investigated in vitro against HIV-1 and other selected viruses. The benzyl 3f and fluorophenyl 3g derivatives showed moderate protection against CVB-2 and the compound 3g also against HSV-1. Derivatives were tested also for their antibacterial and antifungal activity. The molecular structures of 3a and 3d were determined by an X-ray analysis.
Keywords: Antiviral activity; Cytotoxicity; 3-Phenylpiperidine-2,6-dione; X-ray crystallography Antiviral activity; Cytotoxicity; 3-Phenylpiperidine-2,6-dione; X-ray crystallography

Share and Cite

MDPI and ACS Style

BIELENICA, A.; KOSSAKOWSKI, J.; STRUGA, M.; DYBAŁA, I.; LODDO, R.; IBBA, C.; LA COLLA, P. Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]- piperidine-2,6-diones. Sci. Pharm. 2011, 79, 225-238. https://doi.org/10.3797/scipharm.1012-17

AMA Style

BIELENICA A, KOSSAKOWSKI J, STRUGA M, DYBAŁA I, LODDO R, IBBA C, LA COLLA P. Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]- piperidine-2,6-diones. Scientia Pharmaceutica. 2011; 79(2):225-238. https://doi.org/10.3797/scipharm.1012-17

Chicago/Turabian Style

BIELENICA, Anna, Jerzy KOSSAKOWSKI, Marta STRUGA, Izabela DYBAŁA, Roberta LODDO, Cristina IBBA, and Paolo LA COLLA. 2011. "Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]- piperidine-2,6-diones" Scientia Pharmaceutica 79, no. 2: 225-238. https://doi.org/10.3797/scipharm.1012-17

Article Metrics

Back to TopTop